Virax Biolabs Group Limited

NasdaqCM:VRAX Stock Report

Market Cap: US$1.8m

Virax Biolabs Group Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

James Foster

Chief executive officer

US$1.6m

Total compensation

CEO salary percentage15.2%
CEO tenure2yrs
CEO ownership12.2%
Management average tenure1.4yrs
Board average tenure2.2yrs

Recent management updates

Recent updates

Virax stock soars 40% on launch of monkeypox rapid test kits

Sep 20

Virax Biolabs soars 37% on launch of real-time PCR test for monkeypox in Europe

Jul 26

CEO Compensation Analysis

How has James Foster's remuneration changed compared to Virax Biolabs Group's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2023n/an/a

-US$7m

Jun 30 2023n/an/a

-US$6m

Mar 31 2023US$2mUS$248k

-US$5m

Dec 31 2022n/an/a

-US$4m

Sep 30 2022n/an/a

-US$3m

Jun 30 2022n/an/a

-US$2m

Mar 31 2022US$138kUS$138k

-US$2m

Dec 31 2021n/an/a

-US$1m

Sep 30 2021n/an/a

-US$860k

Jun 30 2021n/an/a

-US$755k

Mar 31 2021US$267kn/a

-US$651k

Compensation vs Market: James's total compensation ($USD1.63M) is above average for companies of similar size in the US market ($USD663.45K).

Compensation vs Earnings: James's compensation has increased whilst the company is unprofitable.


CEO

James Foster (38 yo)

2yrs

Tenure

US$1,625,175

Compensation

Mr. James Foster is co-founder of Virax Biolabs Group Limited and has been its Chief Executive Officer and serves as its Director & Chairman since May 2022. From 2014 to July 2018, Mr. Foster co-founded an...


Leadership Team

NamePositionTenureCompensationOwnership
James Foster
Chairman & CEOno dataUS$1.63m12.19%
$ 217.4k
Jason Davis
Chief Financial Officer2.1yrsUS$923.50kno data
Mark Ternouth
Chief Technical Officer & Directorno dataUS$405.56k0.25%
$ 4.5k
Tomasz George
Chief Scientific Officerno dataUS$451.25k1.08%
$ 19.2k
Nigel McCracken
Chief Operating Officerless than a yearno datano data
Joel Yeung
Accounting Manager1.3yrsno datano data
Clement Monteil
Head of Scientific Research & Development1.4yrsno datano data
James Wang
Head of Procurement & Sourcing1.4yrsno datano data
Lily Fu
Head of Supply Chainno datano datano data

1.4yrs

Average Tenure

45yo

Average Age

Experienced Management: VRAX's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
James Foster
Chairman & CEO2yrsUS$1.63m12.19%
$ 217.4k
Mark Ternouth
Chief Technical Officer & Directorless than a yearUS$405.56k0.25%
$ 4.5k
Nikolas Perrault
Member of Advisory Board2.8yrsno datano data
Evan Norton
Independent Director2yrsUS$96.10kno data
Nelson Haight
Independent Director1.5yrsUS$42.18kno data
Cameron Shaw
Member of Advisory Board1.3yrsUS$1.59m8.81%
$ 157.1k
Yair Erez
Independent Director2yrsUS$96.10kno data
Bruce Lavin
Member of Advisory Board2.5yrsno datano data
Pierre Frouin
Member of Advisory Board2.4yrsno datano data
Asaf Gol
Member of Advisory Board2.5yrsno datano data
Ian Hampson
Member of Advisory Board2.7yrsno datano data
Marc Frouin
Member of Advisory Board2.5yrsno datano data

2.2yrs

Average Tenure

49yo

Average Age

Experienced Board: VRAX's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.